Jaw injection may take the ouch out of wisdom tooth surgery
NCT ID NCT07297264
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single injection of betamethasone (a steroid) into the jaw space could reduce pain, swelling, and difficulty opening the mouth after impacted wisdom tooth surgery. Forty healthy adults with similar wisdom teeth on both sides received the steroid on one side and a placebo on the other. The trial was terminated early, so the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- betamethasone
- What this could lead to
- If it works, this could offer a simple way to reduce pain, swelling, and jaw stiffness after wisdom tooth surgery.
- What could go wrong
- The trial was terminated early with only 40 participants, so results may not be reliable. It also only applies to healthy people with specific tooth positions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
40 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
Mar 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 35 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * healthy * no infection * no pain * no limitation of mouth opening * symmetrical bilateral impacted third molars (Mesioangular, CLASS II, Position B Exclusion Criteria: * Infection * systemic disease * smokers * operation time exceeding 30 minutes
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Morbidity are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shehab Ahmed Hamad
Erbil, 00441, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital avatar prepare patients for surgery as well as a nurse?
- Could your own blood speed wisdom tooth healing?
- Common heartburn meds may raise risks for liver patients, new study warns
- Doula care may ease postpartum depression in black mothers
- Old polio vaccine may offer new shield against COVID-19
- Massive french study to reveal if more doctors mean fewer deaths